Stocks Overview

LAST PRICE
2.5500
TODAY'S CHANGE (%)
Trending Down-0.1400 (-5.2045%)

Bid / Lots
2.2800/ 41
Ask / Lots
2.7000/ 5
Open / Previous Close
2.6800 / 2.6900
Day Range
Low 2.5300
High 2.6900
52 Week Range
Low 0.3599
High 6.0400
Volume
611,220
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 2.69
Time	Volume	ADCT
09:32 ET	3294	2.65
09:36 ET	400	2.65
09:45 ET	200	2.64
09:48 ET	400	2.6493
09:52 ET	336	2.64
09:57 ET	1895	2.62
10:01 ET	907	2.62
10:06 ET	512	2.635
10:10 ET	400	2.635
10:12 ET	172	2.63
10:15 ET	900	2.64
10:21 ET	200	2.64
10:24 ET	3063	2.645
10:26 ET	3128	2.64
10:28 ET	3524	2.67
10:30 ET	300	2.67
10:32 ET	516	2.666
10:33 ET	1192	2.655
10:35 ET	824	2.6499
10:37 ET	876	2.655
10:39 ET	2300	2.66
10:44 ET	500	2.655
10:46 ET	1257	2.65
10:48 ET	1200	2.63
10:51 ET	903	2.63
10:55 ET	100	2.63
10:57 ET	100	2.62
11:00 ET	100	2.63
11:02 ET	765	2.63
11:04 ET	7995	2.63
11:06 ET	200	2.635
11:08 ET	400	2.64
11:09 ET	910	2.6397
11:11 ET	2315	2.6289
11:13 ET	900	2.62
11:15 ET	5396	2.6
11:18 ET	3220	2.605
11:20 ET	1500	2.61
11:22 ET	300	2.62
11:24 ET	3768	2.6
11:26 ET	3425	2.6099
11:29 ET	2302	2.61
11:31 ET	400	2.61
11:33 ET	300	2.62
11:36 ET	500	2.61
11:42 ET	200	2.615
11:45 ET	380	2.615
11:47 ET	1856	2.615
11:49 ET	446	2.61
11:51 ET	2596	2.6
11:54 ET	100	2.6
11:56 ET	950	2.6
11:58 ET	100	2.6
12:00 ET	699	2.605
12:02 ET	2125	2.61
12:03 ET	1432	2.61
12:05 ET	100	2.6
12:07 ET	1900	2.61
12:09 ET	5338	2.63
12:12 ET	400	2.6399
12:14 ET	200	2.64
12:16 ET	1522	2.655
12:18 ET	1907	2.63
12:21 ET	181	2.635
12:23 ET	1178	2.63
12:25 ET	371	2.625
12:27 ET	279	2.625
12:30 ET	300	2.63
12:32 ET	6026	2.615
12:36 ET	2226	2.625
12:38 ET	200	2.63
12:39 ET	1181	2.625
12:48 ET	350	2.6208
12:50 ET	100	2.62
12:52 ET	3403	2.655
12:54 ET	100	2.66
12:56 ET	200	2.66
12:57 ET	100	2.66
12:59 ET	200	2.655
01:08 ET	200	2.66
01:14 ET	401	2.655
01:17 ET	3759	2.66
01:19 ET	2038	2.65
01:24 ET	9400	2.665
01:28 ET	2481	2.66
01:30 ET	600	2.66
01:32 ET	1102	2.655
01:35 ET	2077	2.635
01:39 ET	1064	2.635
01:42 ET	2114	2.63
01:44 ET	400	2.63
01:46 ET	300	2.63
01:48 ET	760	2.63
01:50 ET	449	2.63
01:51 ET	100	2.62
01:53 ET	6918	2.61
01:55 ET	281	2.61
01:57 ET	4353	2.63
02:00 ET	379	2.625
02:02 ET	853	2.615
02:04 ET	500	2.61
02:06 ET	1784	2.605
02:08 ET	400	2.6
02:09 ET	2422	2.605
02:11 ET	992	2.605
02:13 ET	300	2.605
02:15 ET	400	2.6
02:18 ET	100	2.6
02:20 ET	271	2.6
02:22 ET	5688	2.59
02:24 ET	279	2.59
02:26 ET	2196	2.59
02:27 ET	10438	2.57
02:29 ET	5488	2.57
02:31 ET	5400	2.57
02:33 ET	5834	2.56
02:36 ET	5863	2.55
02:38 ET	2653	2.55
02:40 ET	6797	2.55
02:42 ET	2200	2.55
02:44 ET	17926	2.59
02:45 ET	2838	2.58
02:47 ET	300	2.575
02:49 ET	8062	2.575
02:51 ET	811	2.57
02:54 ET	26521	2.595
02:56 ET	950	2.6
02:58 ET	4570	2.585
03:00 ET	509	2.58
03:02 ET	1200	2.58
03:03 ET	8100	2.58
03:05 ET	1800	2.58
03:07 ET	2426	2.58
03:09 ET	4362	2.57
03:12 ET	8901	2.59
03:14 ET	1200	2.585
03:16 ET	200	2.585
03:18 ET	707	2.58
03:20 ET	1800	2.585
03:21 ET	3787	2.57
03:23 ET	1921	2.575
03:25 ET	1860	2.57
03:27 ET	33143	2.58
03:30 ET	3197	2.575
03:32 ET	300	2.57
03:34 ET	1063	2.57
03:36 ET	700	2.575
03:38 ET	6586	2.56
03:39 ET	3610	2.56
03:41 ET	13832	2.56
03:43 ET	12993	2.55
03:45 ET	3988	2.55
03:48 ET	3665	2.55
03:50 ET	6715	2.55
03:52 ET	8907	2.55
03:54 ET	8268	2.54
03:56 ET	7038	2.54
03:57 ET	45737	2.54
03:59 ET	39815	2.55

Data delayed at least 15 minutes.

Jun 3, 2024
- ADC Therapeutics Makes Grants to New Employees Under Inducement Plan, from 4:05PM ET on Monday Jun 03, 2024 by Dow Jones
  4:05PM ET on Monday Jun 03, 2024 by Dow Jones
May 30, 2024
- DJ ADC Therapeutics Initiated at Overweight by Cantor Fitzgerald, from 9:06AM ET on Thursday May 30, 2024 by Dow Jones
  9:06AM ET on Thursday May 30, 2024 by Dow Jones
- ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference, from 7:15AM ET on Thursday May 30, 2024 by Dow Jones
  7:15AM ET on Thursday May 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesADCT ADC Therapeutics SA	258.7M	-0.9x	---
United StatesPSTX Poseida Therapeutics Inc	266.6M	-2.2x	---
United StatesCDXS Codexis Inc	211.7M	-3.1x	---
United StatesENTA Enanta Pharmaceuticals Inc	258.8M	-2.0x	---
United StatesMGNX MacroGenics Inc	281.9M	-11.4x	---
United StatesADAP Adaptimmune Therapeutics PLC	225.0M	-1.2x	---
As of 2024-06-25

ADC Therapeutics SA is a Switzerland-based clinical-stage oncology drug discovery and development company. It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers. It employs monoclonal antibodies specific to particular tumor antigens conjugated to a class of pyrrolobenzodiazepine (PBD)-based warheads to selectively target and kill cancer cells. The Company has multiple PBD-based ADCs in ongoing clinical trials, ranging from first in human to pivotal Phase II clinical trials, and numerous preclinical ADCs in development. Its main drug candidates are ADCT-301 for the treatment of lymphoma and leukemia and ADCT-402 for the treatment of non-Hodgkin’s lymphoma and B-cell leukemia. It serves customers in the United States, Switzerland, and the United Kingdom.

Contact Information

Headquarters: Biopole, route de la Corniche 3BEPALINGES, Switzerland 1066
Phone: ---
Fax: ---

Executives

Non-Executive Chairman of the Board: Ron Squarer
Chief Executive Officer, Director: Ameet Mallik
Chief Financial Officer: Jose Carmona
Chief Scientific Officer: Patrick Van Berkel
Chief Legal Officer: Peter Graham

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$258.7M
Revenue (TTM)	$68.6M
Shares Outstanding	96.2M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.58
EPS	$-2.77
Book Value	$-1.80
P/E Ratio	-0.9x
Price/Sales (TTM)	3.8
Price/Cash Flow (TTM)	---
Operating Margin	-216.68%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

ADC Therapeutics SA
NYSE:ADCTUnited States

Search Criteria

Charts

Recent News

Jun 3, 2024

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan, from 4:05PM ET on Monday Jun 03, 2024 by Dow Jones

May 30, 2024

DJ ADC Therapeutics Initiated at Overweight by Cantor Fitzgerald, from 9:06AM ET on Thursday May 30, 2024 by Dow Jones

ADC Therapeutics to Participate in the Jefferies Global Healthcare Conference, from 7:15AM ET on Thursday May 30, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar